RUNX3 encodes Runt-related transcription factor 3, a nuclear Runt-domain DNA-binding transcription factor that heterodimerizes with CBFβ/core-binding factor complexes to regulate RNA polymerase II target-gene programs. Its core function is sequence-specific regulatory DNA and chromatin binding for context-dependent transcriptional activation or repression, with important downstream roles in development, TGF-beta/Wnt/Hippo signaling, CD8 T-cell biology, and cancer-associated mislocalization or degradation.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0000978
RNA polymerase II cis-regulatory region sequence-specific DNA binding
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: RNA polymerase II cis-regulatory region sequence-specific DNA binding is supported by RUNX3 Runt-domain sequence-specific DNA binding.
Reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
|
|
GO:0001503
ossification
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: ossification is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
|
|
GO:0030097
hemopoiesis
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: hemopoiesis is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
|
|
GO:0030182
neuron differentiation
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: neuron differentiation is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
|
|
GO:0045595
regulation of cell differentiation
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: regulation of cell differentiation is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
|
|
GO:0006357
regulation of transcription by RNA polymerase II
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Regulation of transcription by RNA polymerase II is a core RUNX3 biological process.
Reason: RUNX3 regulates gene-expression programs as a nuclear sequence-specific transcription factor.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
|
|
GO:0000981
DNA-binding transcription factor activity, RNA polymerase II-specific
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the best-supported core molecular function of RUNX3.
Reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
|
|
GO:0002062
chondrocyte differentiation
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: chondrocyte differentiation is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
|
|
GO:0003677
DNA binding
|
IEA
GO_REF:0000120 |
MODIFY |
Summary: Generic DNA binding is directionally correct but less precise than RUNX3 sequence-specific regulatory DNA binding.
Reason: RUNX3 is not merely a generic DNA-binding protein; its supported molecular role is sequence-specific Runt-domain binding at regulatory regions.
Proposed replacements:
sequence-specific double-stranded DNA binding
RNA polymerase II cis-regulatory region sequence-specific DNA binding
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
|
|
GO:0003700
DNA-binding transcription factor activity
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: Generic DNA-binding transcription factor activity is correct but less precise than the RNA polymerase II-specific term already present.
Reason: RUNX3 functions as a sequence-specific RNA polymerase II transcription factor, so the more specific term is preferred.
Proposed replacements:
DNA-binding transcription factor activity, RNA polymerase II-specific
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
|
|
GO:0005524
ATP binding
|
IEA
GO_REF:0000002 |
REMOVE |
Summary: ATP binding is not supported as a RUNX3 molecular function.
Reason: RUNX3 is a non-enzymatic DNA-binding transcription factor; ATP-dependent chromatin-remodeling context should not be transferred to RUNX3 as ATP binding.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: cytoplasm localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
|
|
GO:0006355
regulation of DNA-templated transcription
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: Generic regulation of DNA-templated transcription is supported but should be captured with the RNA polymerase II-specific process.
Reason: RUNX3 target-gene regulation is best represented by regulation of transcription by RNA polymerase II.
Proposed replacements:
regulation of transcription by RNA polymerase II
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
|
|
GO:0045893
positive regulation of DNA-templated transcription
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Positive regulation of DNA-templated transcription is supported in context-specific RUNX3 target-gene programs.
Reason: RUNX3 can activate transcriptional targets, although the direction of regulation is context dependent.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 study (Cancer Research Communications) presented evidence that RUNX3 can be **pro-metastatic** in a gastric cancer model (HGC-27), where CRISPR KO reduced migration/invasion/anchorage-independent growth and suppressed liver metastasis in vivo. Multi-omic mapping (ChIP-seq, HiChIP) supported direct transcriptional control of metastasis-associated targets including **WNT5A**, **CD44**, and **VIM**, with WNT5A functioning as a major effector.
|
|
GO:1990837
sequence-specific double-stranded DNA binding
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: sequence-specific double-stranded DNA binding is supported by RUNX3 Runt-domain sequence-specific DNA binding.
Reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
|
|
GO:0005515
protein binding
|
IPI
PMID:18772112 RUNX3 attenuates beta-catenin/T cell factors in intestinal t... |
MARK AS OVER ANNOTATED |
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
|
|
GO:0005515
protein binding
|
IPI
PMID:24229708 Runx3 inactivation is a crucial early event in the developme... |
MARK AS OVER ANNOTATED |
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
|
|
GO:0005515
protein binding
|
IPI
PMID:38424632 Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3... |
MARK AS OVER ANNOTATED |
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
|
|
GO:0005515
protein binding
|
IPI
PMID:9751710 Transcriptional repression by AML1 and LEF-1 is mediated by ... |
MARK AS OVER ANNOTATED |
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
|
|
GO:0005654
nucleoplasm
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005829
cytosol
|
IDA
GO_REF:0000052 |
KEEP AS NON CORE |
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
|
|
GO:0006357
regulation of transcription by RNA polymerase II
|
IDA
PMID:20591170 The Runx transcriptional co-activator, CBFbeta, is essential... |
ACCEPT |
Summary: Regulation of transcription by RNA polymerase II is a core RUNX3 biological process.
Reason: RUNX3 regulates gene-expression programs as a nuclear sequence-specific transcription factor.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
|
|
GO:0001222
transcription corepressor binding
|
IPI
PMID:9751710 Transcriptional repression by AML1 and LEF-1 is mediated by ... |
ACCEPT |
Summary: Transcription corepressor binding is supported by RUNX/Runt-domain recruitment of TLE/Groucho corepressors.
Reason: This is a more informative binding annotation than generic protein binding for RUNX3-associated transcriptional repression.
Supporting Evidence:
PMID:9751710
The mammalian AML/CBFalpha runt domain (RD) transcription factors regulate hematopoiesis and osteoblast differentiation. Like their Drosophila counterparts, most mammalian RD proteins terminate in a common pentapeptide, VWRPY, which serves to recruit the corepressor Groucho (Gro).
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
|
|
GO:1990837
sequence-specific double-stranded DNA binding
|
IDA
PMID:28473536 Impact of cytosine methylation on DNA binding specificities ... |
ACCEPT |
Summary: sequence-specific double-stranded DNA binding is supported by RUNX3 Runt-domain sequence-specific DNA binding.
Reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
|
|
GO:0000785
chromatin
|
ISA
GO_REF:0000113 |
ACCEPT |
Summary: Chromatin localization is supported by RUNX3 DNA, mononucleosome, and chromatin-remodeler-associated activity.
Reason: RUNX3 binds chromatin-associated regulatory DNA as part of its transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 associates with **CBFβ** and chromatin remodeler machinery including SWI/SNF components; the **Runt domain** is implicated as critical for interactions with chromatin factors in this metastatic gastric cancer model.
|
|
GO:0000981
DNA-binding transcription factor activity, RNA polymerase II-specific
|
ISA
GO_REF:0000113 |
ACCEPT |
Summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the best-supported core molecular function of RUNX3.
Reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
|
|
GO:0016513
core-binding factor complex
|
TAS
PMID:18258917 Repression of the transcription factor Th-POK by Runx comple... |
ACCEPT |
Summary: Core-binding factor complex is the canonical RUNX3 transcription factor complex context.
Reason: RUNX3 heterodimerizes with CBFβ, placing it in the core-binding factor complex for DNA-binding transcriptional regulation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 associates with **CBFβ** and chromatin remodeler machinery including SWI/SNF components; the **Runt domain** is implicated as critical for interactions with chromatin factors in this metastatic gastric cancer model.
|
|
GO:0043371
negative regulation of CD4-positive, alpha-beta T cell differentiation
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: negative regulation of CD4-positive, alpha-beta T cell differentiation is a supported RUNX3 biological role, especially in immune differentiation, but it is downstream of the transcription factor core function.
Reason: T-cell differentiation phenotypes reflect RUNX3-regulated transcriptional programs rather than a separate core molecular activity.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is a key regulator of **CD8+ T-cell differentiation, infiltration, effector/memory fate, and residency**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
|
|
GO:0043378
positive regulation of CD8-positive, alpha-beta T cell differentiation
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: positive regulation of CD8-positive, alpha-beta T cell differentiation is a supported RUNX3 biological role, especially in immune differentiation, but it is downstream of the transcription factor core function.
Reason: T-cell differentiation phenotypes reflect RUNX3-regulated transcriptional programs rather than a separate core molecular activity.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is a key regulator of **CD8+ T-cell differentiation, infiltration, effector/memory fate, and residency**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8952419 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8952399 |
KEEP AS NON CORE |
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8952408 |
KEEP AS NON CORE |
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8952382 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8952399 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8951966 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8951977 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8952058 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8952062 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8952069 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8937792 |
KEEP AS NON CORE |
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8937807 |
KEEP AS NON CORE |
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8937814 |
KEEP AS NON CORE |
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8865454 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8878117 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8878143 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8878178 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8878193 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8878220 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8878237 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8937814 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8949335 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8951428 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8951676 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8951910 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8951951 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8952128 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8952226 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-8952371 |
ACCEPT |
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005515
protein binding
|
IPI
PMID:20599712 Tumor suppressor, AT motif binding factor 1 (ATBF1), translo... |
MARK AS OVER ANNOTATED |
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
|
|
GO:0005634
nucleus
|
IDA
PMID:20599712 Tumor suppressor, AT motif binding factor 1 (ATBF1), translo... |
ACCEPT |
Summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0005737
cytoplasm
|
IDA
PMID:20599712 Tumor suppressor, AT motif binding factor 1 (ATBF1), translo... |
KEEP AS NON CORE |
Summary: cytoplasm localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
|
|
GO:0045893
positive regulation of DNA-templated transcription
|
IDA
PMID:20599712 Tumor suppressor, AT motif binding factor 1 (ATBF1), translo... |
ACCEPT |
Summary: Positive regulation of DNA-templated transcription is supported in context-specific RUNX3 target-gene programs.
Reason: RUNX3 can activate transcriptional targets, although the direction of regulation is context dependent.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 study (Cancer Research Communications) presented evidence that RUNX3 can be **pro-metastatic** in a gastric cancer model (HGC-27), where CRISPR KO reduced migration/invasion/anchorage-independent growth and suppressed liver metastasis in vivo. Multi-omic mapping (ChIP-seq, HiChIP) supported direct transcriptional control of metastasis-associated targets including **WNT5A**, **CD44**, and **VIM**, with WNT5A functioning as a major effector.
|
|
GO:0071559
response to transforming growth factor beta
|
IDA
PMID:20599712 Tumor suppressor, AT motif binding factor 1 (ATBF1), translo... |
KEEP AS NON CORE |
Summary: Response to transforming growth factor beta is supported as a pathway context for RUNX3 transcriptional regulation.
Reason: TGF-beta/SMAD effects are important context-specific biology, but the core function remains nuclear sequence-specific transcriptional regulation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
|
|
GO:0005515
protein binding
|
IPI
PMID:17377532 Foxp3 controls regulatory T-cell function by interacting wit... |
MARK AS OVER ANNOTATED |
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
|
|
GO:0000785
chromatin
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Chromatin localization is supported by RUNX3 DNA, mononucleosome, and chromatin-remodeler-associated activity.
Reason: RUNX3 binds chromatin-associated regulatory DNA as part of its transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 associates with **CBFβ** and chromatin remodeler machinery including SWI/SNF components; the **Runt domain** is implicated as critical for interactions with chromatin factors in this metastatic gastric cancer model.
|
|
GO:0000977
RNA polymerase II transcription regulatory region sequence-specific DNA binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: RNA polymerase II transcription regulatory region sequence-specific DNA binding is supported by RUNX3 Runt-domain sequence-specific DNA binding.
Reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
|
|
GO:0000122
negative regulation of transcription by RNA polymerase II
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Negative regulation of transcription by RNA polymerase II is supported for RUNX3 in repressive target-gene and Wnt/TCF contexts.
Reason: RUNX3 can repress transcriptional outputs through protein complexes and target-gene regulation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
PMID:18772112
Here we found that RUNX3, a gastric tumor suppressor, forms a ternary complex with beta-catenin/TCF4 and attenuates Wnt signaling activity.
|
|
GO:0000981
DNA-binding transcription factor activity, RNA polymerase II-specific
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the best-supported core molecular function of RUNX3.
Reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
|
|
GO:0048935
peripheral nervous system neuron development
|
TAS
PMID:20096094 Brn3a regulates neuronal subtype specification in the trigem... |
KEEP AS NON CORE |
Summary: peripheral nervous system neuron development is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
|
|
GO:0005634
nucleus
|
IDA
PMID:20100835 Src kinase phosphorylates RUNX3 at tyrosine residues and loc... |
ACCEPT |
Summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
|
|
GO:0006468
protein phosphorylation
|
IDA
PMID:20100835 Src kinase phosphorylates RUNX3 at tyrosine residues and loc... |
REMOVE |
Summary: Protein phosphorylation is not supported as a process carried out by RUNX3.
Reason: The cited biology describes Src-mediated phosphorylation of RUNX3, making RUNX3 the substrate rather than the kinase or causal gene product for protein phosphorylation.
Supporting Evidence:
PMID:20100835
In this study, we found that the overexpression of Src results in the tyrosine phosphorylation and cytoplasmic localization of RUNX3.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
|
|
GO:0005515
protein binding
|
IPI
PMID:20100835 Src kinase phosphorylates RUNX3 at tyrosine residues and loc... |
MARK AS OVER ANNOTATED |
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:20100835 Src kinase phosphorylates RUNX3 at tyrosine residues and loc... |
KEEP AS NON CORE |
Summary: cytoplasm localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
|
|
GO:0045786
negative regulation of cell cycle
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: negative regulation of cell cycle is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
|
|
GO:0050680
negative regulation of epithelial cell proliferation
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: negative regulation of epithelial cell proliferation is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
|
|
GO:0003700
DNA-binding transcription factor activity
|
TAS
PMID:7607690 Identification of a new murine runt domain-containing gene, ... |
MODIFY |
Summary: Generic DNA-binding transcription factor activity is correct but less precise than the RNA polymerase II-specific term already present.
Reason: RUNX3 functions as a sequence-specific RNA polymerase II transcription factor, so the more specific term is preferred.
Proposed replacements:
DNA-binding transcription factor activity, RNA polymerase II-specific
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
|
|
GO:0005524
ATP binding
|
NAS
PMID:7835892 AML1, AML2, and AML3, the human members of the runt domain g... |
REMOVE |
Summary: ATP binding is not supported as a RUNX3 molecular function.
Reason: RUNX3 is a non-enzymatic DNA-binding transcription factor; ATP-dependent chromatin-remodeling context should not be transferred to RUNX3 as ATP binding.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
|
|
GO:0006355
regulation of DNA-templated transcription
|
NAS
PMID:7622058 Cloning, mapping and expression of PEBP2 alpha C, a third ge... |
MODIFY |
Summary: Generic regulation of DNA-templated transcription is supported but should be captured with the RNA polymerase II-specific process.
Reason: RUNX3 target-gene regulation is best represented by regulation of transcription by RNA polymerase II.
Proposed replacements:
regulation of transcription by RNA polymerase II
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The target protein is human RUNX3 (gene symbol RUNX3, UniProt Q13761), described in UniProt as Runt-related transcription factor 3 with a conserved Runt (AML1_Runt) DNA-binding domain and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β) and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761. However, within the retrieved full-text sources, the UniProt accession “Q13761” is not explicitly mentioned, so mapping is based on concordance of gene/protein name, organism (human), and domain/function description rather than a direct accession cross-reference. (chen2024runxtranscriptionfactors pages 1-2, mahmoud2024runx3actsas pages 6-8)
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved Runt DNA-binding domain; they functionally heterodimerize with CBFβ, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity. This “core-binding factor” logic is foundational for interpreting RUNX3 function as a transcriptional regulator rather than an enzyme or transporter. (chen2024runxtranscriptionfactors pages 1-2)
Beyond “transcription factor” as a label, recent mechanistic work supports RUNX3 as a chromatin-associated regulator with features often attributed to pioneer/chromatin-binding factors:
- RUNX3 can bind DNA and mononucleosomes, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration). (mahmoud2024runx3actsas pages 36-38, mahmoud2024runx3actsas pages 38-43)
- RUNX3 associates with CBFβ and chromatin remodeler machinery including SWI/SNF components; the Runt domain is implicated as critical for interactions with chromatin factors in this metastatic gastric cancer model. (mahmoud2024runx3actsas pages 6-8, mahmoud2024runx3actsas pages 38-43)
Because RUNX3 is a transcription factor, nuclear localization is essential for its canonical function. A recurring cancer mechanism is functional inactivation by cytoplasmic mislocalization (i.e., preventing nuclear transcriptional regulation). RUNX3 mislocalization is not merely correlative: oxidative stress can actively shift RUNX3 from nucleus to cytoplasm via a defined pathway (HDAC1/G9a→Src→RUNX3 phosphorylation→JAB1/CRM1-mediated export), coupled to proteasomal loss. (kang2024oxidativestressmediatedrunx3 pages 4-9, kang2024oxidativestressmediatedrunx3 pages 9-13)
A key 2023 advance demonstrated a direct protein–protein mechanism linking RUNX3 to oncogene control: RUNX3 binds MYC directly via the Runt domain, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases GSK3β-mediated phosphorylation of MYC at T58, and promotes FBXW7-dependent K48-linked ubiquitination and proteasomal degradation of MYC. This provides a concrete molecular basis for tumor-suppressive activity in contexts where MYC is a driver. (oei2023runx3inactivatesoncogenic pages 1-2, oei2023runx3inactivatesoncogenic pages 4-7, oei2023runx3inactivatesoncogenic pages 7-9, oei2023runx3inactivatesoncogenic pages 9-11)
Quantitative kinetic evidence was provided in cell systems: RUNX3 expression shortened MYC half-life (e.g., ~30→20 minutes in one system and ~32→23 minutes in another), supporting rapid post-translational control. (oei2023runx3inactivatesoncogenic pages 4-7)
A 2024 study elucidated a pathway by which oxidative stress in colon cancer cells induces RUNX3 inactivation by nuclear export and cytoplasmic accumulation, integrating chromatin-modifier activity with signaling:
- Oxidative stress increased HDAC1 and G9a/EHMT2 and activated Src, resulting in RUNX3 tyrosine phosphorylation.
- RUNX3 interacted with JAB1 and CRM1, promoting CRM1-dependent export and proteasome-mediated depletion; JAB1 knockdown or CRM1 inhibition restored nuclear RUNX3.
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss. (kang2024oxidativestressmediatedrunx3 pages 4-9, kang2024oxidativestressmediatedrunx3 pages 9-13)
A 2024 translational mechanistic study in lung adenocarcinoma (LUAD) reported that the RNA-binding E3 ligase MEX3C promotes tumor phenotypes by ubiquitylating and degrading RUNX3 (protein-level regulation without corresponding mRNA change). The same study supports a downstream transcriptional axis where RUNX3 represses Suv39H1, positioning MEX3C→RUNX3↓→Suv39H1↑ as a tumor-promoting pathway. (he2024ubiquitylationofrunx3 pages 9-11, he2024ubiquitylationofrunx3 pages 11-15)
A 2024 study (Cancer Research Communications) presented evidence that RUNX3 can be pro-metastatic in a gastric cancer model (HGC-27), where CRISPR KO reduced migration/invasion/anchorage-independent growth and suppressed liver metastasis in vivo. Multi-omic mapping (ChIP-seq, HiChIP) supported direct transcriptional control of metastasis-associated targets including WNT5A, CD44, and VIM, with WNT5A functioning as a major effector. This highlights a key modern theme: RUNX3 can act as tumor suppressor or oncogenic driver depending on cellular context and regulatory state. (suda2024aberrantupregulationof pages 5-8, suda2024aberrantupregulationof pages 8-10, suda2024aberrantupregulationof pages 1-2, suda2024aberrantupregulationof pages 10-11)
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including TGF-β/SMAD, Wnt/β-catenin, and Hippo–YAP crosstalk, and emphasizes frequent RUNX3 inactivation through promoter hypermethylation, histone modifications, and mislocalization. (chen2024runxtranscriptionfactors pages 1-2, chen2024runxtranscriptionfactors pages 18-19)
Within TGF-β signaling specifically, the 2024 review cites contexts where RUNX3 overexpression suppresses Smad2/3 phosphorylation and inhibits TGF-β/Smad-driven EMT and invasion, while also noting context-dependence (e.g., SMAD4/Dpc4 status in pancreatic cancer). (chen2024runxtranscriptionfactors pages 12-14)
A 2023 Molecular Cancer study connects RUNX3 to a clinically relevant immunotherapy strategy: decitabine (DNA-demethylating agent) priming can demethylate the RUNX3 promoter in CD8+ T cells, increase RUNX3 expression, promote CD8+ infiltration, and reduce exhaustion; crucially, conditional Runx3 loss in T cells abrogated the benefit of decitabine as a sensitizer for anti-PD-1 therapy in mouse models. (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4, liu2023epigeneticreprogrammingof pages 9-12, liu2023epigeneticreprogrammingof pages 7-9)
This work explicitly reports clinically relevant response statistics (from prior clinical work cited within the paper): combining low-dose decitabine with PD-1 blockade increased complete response in classical Hodgkin lymphoma from 32% to 71%. (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4)
A direct “real-world implementation” of RUNX3 biology is its use as an engineered transcription factor cargo in CAR-T products. Fu et al. reported a first-in-human, single-center, single-arm phase I trial (NCT03980288) of CT017, a GPC3-targeting CAR T cell product that co-expresses RUNX3 (via an F2A peptide) for heavily pretreated, GPC3+ hepatocellular carcinoma. (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 2-3)
Key clinical statistics:
- N=6 evaluable patients (7 infusions; one patient treated twice); dose 250×10^6 cells. (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 5-6)
- Safety: cytokine release syndrome (CRS) occurred in all patients; 3/6 grade 3 CRS; no ICANS observed; CRS resolved. (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 6-7, fu2023runx3expressingcart media 6458455b)
- Efficacy: ORR 16.7% (1 partial response) and DCR 50% (PR+SD); median PFS 3.5 months; median OS 7.9 months. (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 7-8)
- Persistence: CAR-GPC3 DNA peaked around day 7 and was detectable at day 28, with reported persistence duration (median ~34 days). (fu2023runx3expressingcart pages 6-7, fu2023runx3expressingcart media 006d89ce)
(Visual evidence supporting the above endpoints is available in the trial’s Table/Figure crops.) (fu2023runx3expressingcart media 6458455b, fu2023runx3expressingcart media 006d89ce, fu2023runx3expressingcart media 9604a628)
Recent reviews converge on several expert-level interpretations:
1. RUNX3 is a master developmental transcription factor whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.). (chen2024runxtranscriptionfactors pages 1-2, chen2024runxtranscriptionfactors pages 18-19)
2. RUNX3 exhibits context dependence, with the same factor acting as tumor suppressor or tumor promoter depending on tumor type, stage, co-mutations, and signaling context. (chen2024runxtranscriptionfactors pages 18-19, chen2024runxtranscriptionfactors pages 12-14, suda2024aberrantupregulationof pages 5-8)
3. Non-genetic mechanisms—promoter hypermethylation, histone/chromatin changes, and protein mislocalization—are repeatedly emphasized as major routes to RUNX3 functional loss, often more prominent than coding mutations. (chen2024runxtranscriptionfactors pages 1-2, kang2024oxidativestressmediatedrunx3 pages 4-9)
A 2023 gastric cancer Hippo-pathway review specifically highlights a downstream mechanism in which factors including RUNX3 can bind TEAD and antagonize YAP–TEAD interaction via competitive binding dynamics, positioning RUNX3 as a negative regulator of oncogenic YAP/TEAD transcriptional output in relevant contexts. (messina2023hippopathwaydysregulation pages 2-3, messina2023hippopathwaydysregulation pages 10-11)
Open Targets links RUNX3 to immune/allergic disease phenotypes (e.g., asthma, psoriasis, allergic rhinitis, eczematoid dermatitis) with moderate association scores and supporting literature evidence counts, consistent with RUNX3’s known roles in immune cell differentiation and tissue inflammation. (OpenTargets Search: -RUNX3)
RUNX3 is not an enzyme and does not catalyze a chemical reaction; its primary function is as a sequence-specific DNA-binding transcription factor that regulates gene expression programs by binding target regulatory elements via the Runt domain, typically stabilized by heterodimerization with CBFβ. (chen2024runxtranscriptionfactors pages 1-2)
RUNX3’s canonical site of action is the nucleus, where it binds chromatin and regulates transcription. Multiple studies emphasize that cytoplasmic mislocalization can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery. (kang2024oxidativestressmediatedrunx3 pages 4-9, kang2024oxidativestressmediatedrunx3 pages 9-13)
The following table consolidates RUNX3 identity, pathways, localization, and translational evidence, emphasizing 2023–2024 results and quantitative endpoints:
| Aspect | Summary for human RUNX3 (UniProt Q13761) | Representative recent study / quantitative detail |
|---|---|---|
| Molecular identity | RUNX3 matches the human Runt-related transcription factor 3 described for UniProt Q13761; RUNX proteins are sequence-specific transcription factors with a conserved Runt DNA-binding domain that heterodimerize with CBFβ, which stabilizes DNA binding and transcriptional function. RUNX3 is repeatedly discussed in cancer and immune literature as this CBFβ-partnered Runt-domain TF, consistent with the UniProt annotation and domain architecture (chen2024runxtranscriptionfactors pages 1-2, mahmoud2024runx3actsas pages 6-8). | Chen et al., 2024-03, Clinical and Experimental Medicine, https://doi.org/10.1007/s10238-023-01281-0; Mahmoud et al., 2024-08, bioRxiv, https://doi.org/10.1101/2024.08.16.608297 (chen2024runxtranscriptionfactors pages 1-2, mahmoud2024runx3actsas pages 6-8) |
| Primary molecular functions | RUNX3 functions as a DNA-binding transcriptional regulator and protein-interaction hub. Beyond canonical transcriptional control, recent work supports chromatin/pioneer-like activity: RUNX3 binds DNA and mononucleosomes, associates with SWI/SNF and other chromatin factors, and the Runt domain is required for interactions with chromatin remodelers. Proteomics identified 1,227 candidate interacting proteins, with enrichment for ATP-dependent chromatin remodeling; RUNX3 loss reduced SWI/SNF components and altered chromatin accessibility/transcriptional programs (mahmoud2024runx3actsas pages 6-8, mahmoud2024runx3actsas pages 36-38, mahmoud2024runx3actsas pages 38-43, mahmoud2024runx3actsas pages 24-26). | Mahmoud et al., 2024-08, https://doi.org/10.1101/2024.08.16.608297; tissue array n=59, KM-plotter gastric cohort n=875; low vs high RUNX3 groups 526 vs 349, P=0.0002 (mahmoud2024runx3actsas pages 6-8, mahmoud2024runx3actsas pages 38-43) |
| TGF-β/SMAD axis | RUNX3 is a major RUNX-family node in TGF-β signaling. Review-level synthesis indicates that RUNX3 overexpression can suppress Smad2/3 phosphorylation, inhibit TGF-β/Smad-driven EMT/invasion, and that loss of RUNX3 by hypermethylation is linked to metastatic progression. However, this role is context dependent; in pancreatic ductal adenocarcinoma, RUNX3 may restrain proliferation yet facilitate migration/invasion depending on SMAD4/Dpc4 status (chen2024runxtranscriptionfactors pages 12-14, chen2024runxtranscriptionfactors pages 17-18). | Chen et al., 2024-03, https://doi.org/10.1007/s10238-023-01281-0 (chen2024runxtranscriptionfactors pages 12-14, chen2024runxtranscriptionfactors pages 17-18) |
| Hippo–YAP/TEAD axis | RUNX3 is described as a negative regulator of the oncogenic TEAD–YAP complex. Recent reviews summarize that RUNX3 can bind TEAD competitively and antagonize YAP–TEAD transcriptional output, placing RUNX3 as a Hippo-pathway brake; gastric-cancer Hippo review cites RUNX3 among factors that inhibit YAP–TEAD interaction in a competitive dynamic (chen2024runxtranscriptionfactors pages 18-19, messina2023hippopathwaydysregulation pages 2-3, messina2023hippopathwaydysregulation pages 10-11). | Messina et al., 2023-01, Cell Death & Disease, https://doi.org/10.1038/s41419-023-05568-8; Chen et al., 2024-03, https://doi.org/10.1007/s10238-023-01281-0 (chen2024runxtranscriptionfactors pages 18-19, messina2023hippopathwaydysregulation pages 2-3, messina2023hippopathwaydysregulation pages 10-11) |
| MYC control / tumor-suppressive protein interaction | A 2023 mechanistic study showed RUNX3 directly binds MYC via the Runt domain, disrupts MYC–MAX and MYC–MIZ1 complexes, enhances GSK3β-mediated T58 phosphorylation, recruits FBXW7, and drives K48-linked ubiquitin-proteasomal MYC degradation. Interaction occurs mainly in the nucleus, and a Runt-domain mutant (R122C) loses this MYC-destabilizing activity (oei2023runx3inactivatesoncogenic pages 1-2, oei2023runx3inactivatesoncogenic pages 4-7, oei2023runx3inactivatesoncogenic pages 7-9, oei2023runx3inactivatesoncogenic pages 9-11). | Oei et al., 2023-07, Communications Biology, https://doi.org/10.1038/s42003-023-05037-0; MYC half-life shortened from ~30→20 min in HeLa and ~32→23 min in MKN28 with RUNX3 expression (oei2023runx3inactivatesoncogenic pages 4-7) |
| Subcellular localization / inactivation | RUNX3 is primarily a nuclear transcription factor, but cytoplasmic mislocalization is a recurrent inactivation mechanism in cancer. Oxidative stress can drive nuclear-to-cytoplasmic relocalization through HDAC1/G9a upregulation → Src activation → RUNX3 tyrosine phosphorylation → JAB1/CRM1-mediated export, with subsequent proteasomal degradation; NAC, HDAC1/G9a knockdown, JAB1 knockdown, or CRM1 inhibition restore nuclear RUNX3 (chen2024runxtranscriptionfactors pages 1-2, kang2024oxidativestressmediatedrunx3 pages 4-9, kang2024oxidativestressmediatedrunx3 pages 9-13, kang2024oxidativestressmediatedrunx3 pages 1-4). | Kang et al., 2024-04, Applied Biochemistry and Biotechnology, https://doi.org/10.1007/s12010-024-04944-0; oxidative stress model used 100 μM H2O2 (kang2024oxidativestressmediatedrunx3 pages 4-9) |
| Post-translational downregulation by MEX3C | In lung adenocarcinoma, the RNA-binding E3 ligase MEX3C binds RUNX3 and promotes RUNX3 ubiquitylation/proteasomal degradation, without materially changing RUNX3 mRNA. Downstream, RUNX3 represses Suv39H1; thus the MEX3C→RUNX3↓→Suv39H1↑ axis promotes proliferation, migration, invasion, EMT-like programs, and tumor growth/metastasis (he2024ubiquitylationofrunx3 pages 9-11, he2024ubiquitylationofrunx3 pages 11-15, he2024ubiquitylationofrunx3 pages 6-9). | He et al., 2024-02, Journal of Translational Medicine, https://doi.org/10.1186/s12967-023-04700-8; clinical LUAD cohort n=55 paired tumors, MEX3C–RUNX3 mRNA correlation r = -0.6151, p < 0.0001; xenograft/metastasis assays reported n=5/group (he2024ubiquitylationofrunx3 pages 11-15, he2024ubiquitylationofrunx3 pages 15-18, he2024ubiquitylationofrunx3 pages 6-9) |
| WNT5A / gastric metastasis axis | RUNX3 can also act pro-metastatically in gastric cancer. CRISPR KO in HGC-27 cells reduced migration, invasion, anchorage-independent growth, xenograft growth, and liver metastasis. Multi-omic mapping showed RUNX3 directly regulates metastasis/developmental genes including WNT5A, CD44, VIM, with ChIP-seq and HiChIP linking RUNX3-bound distal elements/promoters to these loci; WNT5A emerged as a main functional effector (suda2024aberrantupregulationof pages 5-8, suda2024aberrantupregulationof pages 8-10, suda2024aberrantupregulationof pages 1-2, suda2024aberrantupregulationof pages 11-13). | Suda et al., 2024-02, Cancer Research Communications, https://doi.org/10.1158/2767-9764.crc-22-0165; resected tumor IF showed RUNX3–WNT5A correlation in cancer cells n=35, Pearson r = 0.4744, P < 0.01 (suda2024aberrantupregulationof pages 11-13) |
| CD8+ T-cell differentiation / immunotherapy | RUNX3 is a key regulator of CD8+ T-cell differentiation, infiltration, effector/memory fate, and residency. In Hodgkin lymphoma immunotherapy studies, promoter P2 demethylation increased RUNX3 expression, promoted CD8+ TIL infiltration, reduced exhaustion, and was required for decitabine (DAC) to sensitize tumors to anti-PD-1; conditional Runx3 loss reduced effector/memory T cells and CCR3/CCR5 and abrogated DAC benefit (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4, liu2023epigeneticreprogrammingof pages 9-12, liu2023epigeneticreprogrammingof pages 7-9). | Liu et al., 2023-05, Molecular Cancer, https://doi.org/10.1186/s12943-023-01768-0; low-dose DAC + anti-PD-1 increased complete response in cHL from 32% to 71%; prior PD-1 failures had 70% re-response and 28% CR; EPIC/RNA-seq high-throughput subset 10 samples; 829,120 CpGs in 25 samples after QC; qRT-PCR cohort 48 patients (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4, liu2023epigeneticreprogrammingof pages 4-5) |
| Real-world implementation: RUNX3-engineered cell therapy | RUNX3 has already been used in a first-in-human CAR-T implementation: CT017 co-expresses a GPC3 CAR and RUNX3 (via F2A peptide) to enhance tumor infiltration, persistence, and tissue-resident features. This is a real-world therapeutic implementation of RUNX3 biology in advanced hepatocellular carcinoma (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 2-3, fu2023runx3expressingcart pages 10-10). | Fu et al., 2023-09, eClinicalMedicine, https://doi.org/10.1016/j.eclinm.2023.102175; phase I, N=6 evaluable, 1 PR + 2 SD → ORR 16.7%, DCR 50%, median PFS 3.5 mo, median OS 7.9 mo; all had CRS, 3/6 grade 3, no ICANS; CAR DNA peaked day 7, detectable median 34 days (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 7-8, fu2023runx3expressingcart pages 6-7, fu2023runx3expressingcart media 6458455b) |
| Biomarker / prognostic use | Current expert opinion supports RUNX3 as a biomarker candidate rather than a routine standalone clinical marker. RUNX3 expression or pathway signatures have been associated with prognosis, immunotherapy response, and epigenetic state; reviews emphasize its potential value but also note strong tumor-context dependence and bidirectional roles in solid tumors (chen2024runxtranscriptionfactors pages 18-19, chen2024runxtranscriptionfactors pages 17-18, liu2023epigeneticreprogrammingof pages 12-14). | Wang et al., 2024-01, BMC Urology, https://doi.org/10.1186/s12894-023-01356-w; in advanced RCC, high RUNX3 pathway signature associated with shorter PFS in two IO/TKI cohorts (P=0.025 and P=0.019) and correlated with fewer GZMB+ CD8+ T cells (ρ = -0.42, P=0.006) (liu2023epigeneticreprogrammingof pages 12-14) |
| Disease-association landscape | Open Targets links RUNX3 to immune/allergic disease traits including asthma, psoriasis, allergic rhinitis, eczematoid dermatitis, supporting its broader immunoregulatory relevance beyond cancer, though evidence strength is moderate and disease-specific mechanisms vary (OpenTargets Search: -RUNX3). | Open Targets association scores: asthma 0.5383, psoriasis 0.5274, allergic disease 0.5233, allergic rhinitis 0.4926, eczematoid dermatitis 0.4782 (OpenTargets Search: -RUNX3) |
Table: This table condenses verified identity, mechanisms, localization, pathways, and translational evidence for human RUNX3 (UniProt Q13761). It is designed to support a comprehensive annotation narrative while highlighting key 2023–2024 studies and quantitative findings.
References
(chen2024runxtranscriptionfactors pages 1-2): Xinyi Chen, Lu Wang, Mu Yang, Weiheng Zhao, Jingyao Tu, Bo Liu, and Xianglin Yuan. Runx transcription factors: biological functions and implications in cancer. Clinical and Experimental Medicine, Mar 2024. URL: https://doi.org/10.1007/s10238-023-01281-0, doi:10.1007/s10238-023-01281-0. This article has 17 citations and is from a peer-reviewed journal.
(mahmoud2024runx3actsas pages 6-8): Salma Awad Mahmoud, Isabelle Bonne, Aik Yong Sim, and Gehan Labib Abuelenain. Runx3 acts as homodimeric chromatin binding factor regulating heterochromatin-mediated cancerous phenotype. bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.08.16.608297, doi:10.1101/2024.08.16.608297. This article has 1 citations.
(mahmoud2024runx3actsas pages 36-38): Salma Awad Mahmoud, Isabelle Bonne, Aik Yong Sim, and Gehan Labib Abuelenain. Runx3 acts as homodimeric chromatin binding factor regulating heterochromatin-mediated cancerous phenotype. bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.08.16.608297, doi:10.1101/2024.08.16.608297. This article has 1 citations.
(mahmoud2024runx3actsas pages 38-43): Salma Awad Mahmoud, Isabelle Bonne, Aik Yong Sim, and Gehan Labib Abuelenain. Runx3 acts as homodimeric chromatin binding factor regulating heterochromatin-mediated cancerous phenotype. bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.08.16.608297, doi:10.1101/2024.08.16.608297. This article has 1 citations.
(kang2024oxidativestressmediatedrunx3 pages 4-9): Kyoung Ah Kang, Mei Jing Piao, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Udari Lakmini Herath, Hye-Jin Boo, Sang Pil Yoon, and Jin Won Hyun. Oxidative stress-mediated runx3 mislocalization occurs via jun activation domain-binding protein 1 and histone modification. Applied Biochemistry and Biotechnology, 196:8082-8095, Apr 2024. URL: https://doi.org/10.1007/s12010-024-04944-0, doi:10.1007/s12010-024-04944-0. This article has 7 citations and is from a peer-reviewed journal.
(kang2024oxidativestressmediatedrunx3 pages 9-13): Kyoung Ah Kang, Mei Jing Piao, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Udari Lakmini Herath, Hye-Jin Boo, Sang Pil Yoon, and Jin Won Hyun. Oxidative stress-mediated runx3 mislocalization occurs via jun activation domain-binding protein 1 and histone modification. Applied Biochemistry and Biotechnology, 196:8082-8095, Apr 2024. URL: https://doi.org/10.1007/s12010-024-04944-0, doi:10.1007/s12010-024-04944-0. This article has 7 citations and is from a peer-reviewed journal.
(oei2023runx3inactivatesoncogenic pages 1-2): Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo, Supriya Srivastava, Ming Teh, and Yoshiaki Ito. Runx3 inactivates oncogenic myc through disruption of myc/max complex and subsequent recruitment of gsk3β-fbxw7 cascade. Communications Biology, Jul 2023. URL: https://doi.org/10.1038/s42003-023-05037-0, doi:10.1038/s42003-023-05037-0. This article has 5 citations and is from a peer-reviewed journal.
(oei2023runx3inactivatesoncogenic pages 4-7): Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo, Supriya Srivastava, Ming Teh, and Yoshiaki Ito. Runx3 inactivates oncogenic myc through disruption of myc/max complex and subsequent recruitment of gsk3β-fbxw7 cascade. Communications Biology, Jul 2023. URL: https://doi.org/10.1038/s42003-023-05037-0, doi:10.1038/s42003-023-05037-0. This article has 5 citations and is from a peer-reviewed journal.
(oei2023runx3inactivatesoncogenic pages 7-9): Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo, Supriya Srivastava, Ming Teh, and Yoshiaki Ito. Runx3 inactivates oncogenic myc through disruption of myc/max complex and subsequent recruitment of gsk3β-fbxw7 cascade. Communications Biology, Jul 2023. URL: https://doi.org/10.1038/s42003-023-05037-0, doi:10.1038/s42003-023-05037-0. This article has 5 citations and is from a peer-reviewed journal.
(oei2023runx3inactivatesoncogenic pages 9-11): Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo, Supriya Srivastava, Ming Teh, and Yoshiaki Ito. Runx3 inactivates oncogenic myc through disruption of myc/max complex and subsequent recruitment of gsk3β-fbxw7 cascade. Communications Biology, Jul 2023. URL: https://doi.org/10.1038/s42003-023-05037-0, doi:10.1038/s42003-023-05037-0. This article has 5 citations and is from a peer-reviewed journal.
(he2024ubiquitylationofrunx3 pages 9-11): Zelai He, Huijun Zhang, Hai-bo Xiao, Xiangyu Zhang, Hongbo Xu, Ruifen Sun, and Siwen Li. Ubiquitylation of runx3 by rna-binding ubiquitin ligase mex3c promotes tumorigenesis in lung adenocarcinoma. Journal of Translational Medicine, Feb 2024. URL: https://doi.org/10.1186/s12967-023-04700-8, doi:10.1186/s12967-023-04700-8. This article has 10 citations and is from a peer-reviewed journal.
(he2024ubiquitylationofrunx3 pages 11-15): Zelai He, Huijun Zhang, Hai-bo Xiao, Xiangyu Zhang, Hongbo Xu, Ruifen Sun, and Siwen Li. Ubiquitylation of runx3 by rna-binding ubiquitin ligase mex3c promotes tumorigenesis in lung adenocarcinoma. Journal of Translational Medicine, Feb 2024. URL: https://doi.org/10.1186/s12967-023-04700-8, doi:10.1186/s12967-023-04700-8. This article has 10 citations and is from a peer-reviewed journal.
(suda2024aberrantupregulationof pages 5-8): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.
(suda2024aberrantupregulationof pages 8-10): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.
(suda2024aberrantupregulationof pages 1-2): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.
(suda2024aberrantupregulationof pages 10-11): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.
(chen2024runxtranscriptionfactors pages 18-19): Xinyi Chen, Lu Wang, Mu Yang, Weiheng Zhao, Jingyao Tu, Bo Liu, and Xianglin Yuan. Runx transcription factors: biological functions and implications in cancer. Clinical and Experimental Medicine, Mar 2024. URL: https://doi.org/10.1007/s10238-023-01281-0, doi:10.1007/s10238-023-01281-0. This article has 17 citations and is from a peer-reviewed journal.
(chen2024runxtranscriptionfactors pages 12-14): Xinyi Chen, Lu Wang, Mu Yang, Weiheng Zhao, Jingyao Tu, Bo Liu, and Xianglin Yuan. Runx transcription factors: biological functions and implications in cancer. Clinical and Experimental Medicine, Mar 2024. URL: https://doi.org/10.1007/s10238-023-01281-0, doi:10.1007/s10238-023-01281-0. This article has 17 citations and is from a peer-reviewed journal.
(liu2023epigeneticreprogrammingof pages 1-2): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.
(liu2023epigeneticreprogrammingof pages 2-4): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.
(liu2023epigeneticreprogrammingof pages 9-12): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.
(liu2023epigeneticreprogrammingof pages 7-9): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.
(fu2023runx3expressingcart pages 1-2): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.
(fu2023runx3expressingcart pages 2-3): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.
(fu2023runx3expressingcart pages 5-6): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.
(fu2023runx3expressingcart pages 6-7): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.
(fu2023runx3expressingcart media 6458455b): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.
(fu2023runx3expressingcart pages 7-8): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.
(fu2023runx3expressingcart media 006d89ce): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.
(fu2023runx3expressingcart media 9604a628): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.
(messina2023hippopathwaydysregulation pages 2-3): Beatrice Messina, Federica Lo Sardo, Stefano Scalera, Lorenzo Memeo, Cristina Colarossi, Marzia Mare, Giovanni Blandino, Gennaro Ciliberto, Marcello Maugeri-Saccà, and Giulia Bon. Hippo pathway dysregulation in gastric cancer: from helicobacter pylori infection to tumor promotion and progression. Cell Death & Disease, Jan 2023. URL: https://doi.org/10.1038/s41419-023-05568-8, doi:10.1038/s41419-023-05568-8. This article has 67 citations and is from a peer-reviewed journal.
(messina2023hippopathwaydysregulation pages 10-11): Beatrice Messina, Federica Lo Sardo, Stefano Scalera, Lorenzo Memeo, Cristina Colarossi, Marzia Mare, Giovanni Blandino, Gennaro Ciliberto, Marcello Maugeri-Saccà, and Giulia Bon. Hippo pathway dysregulation in gastric cancer: from helicobacter pylori infection to tumor promotion and progression. Cell Death & Disease, Jan 2023. URL: https://doi.org/10.1038/s41419-023-05568-8, doi:10.1038/s41419-023-05568-8. This article has 67 citations and is from a peer-reviewed journal.
(liu2023epigeneticreprogrammingof pages 4-5): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.
(he2024ubiquitylationofrunx3 pages 6-9): Zelai He, Huijun Zhang, Hai-bo Xiao, Xiangyu Zhang, Hongbo Xu, Ruifen Sun, and Siwen Li. Ubiquitylation of runx3 by rna-binding ubiquitin ligase mex3c promotes tumorigenesis in lung adenocarcinoma. Journal of Translational Medicine, Feb 2024. URL: https://doi.org/10.1186/s12967-023-04700-8, doi:10.1186/s12967-023-04700-8. This article has 10 citations and is from a peer-reviewed journal.
(suda2024aberrantupregulationof pages 11-13): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.
(OpenTargets Search: -RUNX3): Open Targets Query (-RUNX3, 6 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(mahmoud2024runx3actsas pages 24-26): Salma Awad Mahmoud, Isabelle Bonne, Aik Yong Sim, and Gehan Labib Abuelenain. Runx3 acts as homodimeric chromatin binding factor regulating heterochromatin-mediated cancerous phenotype. bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.08.16.608297, doi:10.1101/2024.08.16.608297. This article has 1 citations.
(chen2024runxtranscriptionfactors pages 17-18): Xinyi Chen, Lu Wang, Mu Yang, Weiheng Zhao, Jingyao Tu, Bo Liu, and Xianglin Yuan. Runx transcription factors: biological functions and implications in cancer. Clinical and Experimental Medicine, Mar 2024. URL: https://doi.org/10.1007/s10238-023-01281-0, doi:10.1007/s10238-023-01281-0. This article has 17 citations and is from a peer-reviewed journal.
(kang2024oxidativestressmediatedrunx3 pages 1-4): Kyoung Ah Kang, Mei Jing Piao, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Udari Lakmini Herath, Hye-Jin Boo, Sang Pil Yoon, and Jin Won Hyun. Oxidative stress-mediated runx3 mislocalization occurs via jun activation domain-binding protein 1 and histone modification. Applied Biochemistry and Biotechnology, 196:8082-8095, Apr 2024. URL: https://doi.org/10.1007/s12010-024-04944-0, doi:10.1007/s12010-024-04944-0. This article has 7 citations and is from a peer-reviewed journal.
(he2024ubiquitylationofrunx3 pages 15-18): Zelai He, Huijun Zhang, Hai-bo Xiao, Xiangyu Zhang, Hongbo Xu, Ruifen Sun, and Siwen Li. Ubiquitylation of runx3 by rna-binding ubiquitin ligase mex3c promotes tumorigenesis in lung adenocarcinoma. Journal of Translational Medicine, Feb 2024. URL: https://doi.org/10.1186/s12967-023-04700-8, doi:10.1186/s12967-023-04700-8. This article has 10 citations and is from a peer-reviewed journal.
(fu2023runx3expressingcart pages 10-10): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.
(liu2023epigeneticreprogrammingof pages 12-14): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.
id: Q13761
gene_symbol: RUNX3
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: 'RUNX3 encodes Runt-related transcription factor 3, a nuclear Runt-domain DNA-binding transcription
factor that heterodimerizes with CBFβ/core-binding factor complexes to regulate RNA polymerase II target-gene
programs. Its core function is sequence-specific regulatory DNA and chromatin binding for context-dependent
transcriptional activation or repression, with important downstream roles in development, TGF-beta/Wnt/Hippo
signaling, CD8 T-cell biology, and cancer-associated mislocalization or degradation.'
existing_annotations:
- term:
id: GO:0000978
label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: RNA polymerase II cis-regulatory region sequence-specific DNA binding is supported by
RUNX3 Runt-domain sequence-specific DNA binding.
action: ACCEPT
reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor
function.
supported_by: &id003
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
primary function is as a **sequence-specific DNA-binding transcription factor** that
regulates gene expression programs by binding target regulatory elements via the **Runt
domain**, typically stabilized by heterodimerization with **CBFβ**.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt
**Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved
**Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the
literature retrieved here, the entity called RUNX3 is consistently described as a
**Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)**
and regulates gene expression through sequence-specific DNA binding—matching the defining
biochemical/structural properties expected for UniProt Q13761.
- term:
id: GO:0001503
label: ossification
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: ossification is consistent with RUNX3 developmental or disease-associated
transcriptional programs but is not the core molecular function.
action: KEEP_AS_NON_CORE
reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
RUNX3 transcription factor activity and should not be treated as the core function itself.
supported_by: &id001
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: '**RUNX3 is a master developmental transcription factor** whose dysregulation can
impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).'
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator
embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and
**Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter
hypermethylation, histone modifications, and mislocalization**.
- term:
id: GO:0030097
label: hemopoiesis
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: hemopoiesis is consistent with RUNX3 developmental or disease-associated
transcriptional programs but is not the core molecular function.
action: KEEP_AS_NON_CORE
reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
RUNX3 transcription factor activity and should not be treated as the core function itself.
supported_by: *id001
- term:
id: GO:0030182
label: neuron differentiation
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: neuron differentiation is consistent with RUNX3 developmental or disease-associated
transcriptional programs but is not the core molecular function.
action: KEEP_AS_NON_CORE
reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
RUNX3 transcription factor activity and should not be treated as the core function itself.
supported_by: *id001
- term:
id: GO:0045595
label: regulation of cell differentiation
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: regulation of cell differentiation is consistent with RUNX3 developmental or
disease-associated transcriptional programs but is not the core molecular function.
action: KEEP_AS_NON_CORE
reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
RUNX3 transcription factor activity and should not be treated as the core function itself.
supported_by: *id001
- term:
id: GO:0006357
label: regulation of transcription by RNA polymerase II
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Regulation of transcription by RNA polymerase II is a core RUNX3 biological process.
action: ACCEPT
reason: RUNX3 regulates gene-expression programs as a nuclear sequence-specific transcription
factor.
supported_by: &id002
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
primary function is as a **sequence-specific DNA-binding transcription factor** that
regulates gene expression programs by binding target regulatory elements via the **Runt
domain**, typically stabilized by heterodimerization with **CBFβ**.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors
defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with
CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and
modulates transcriptional activity.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin
accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
- term:
id: GO:0000981
label: DNA-binding transcription factor activity, RNA polymerase II-specific
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the
best-supported core molecular function of RUNX3.
action: ACCEPT
reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA
polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
supported_by: *id002
- term:
id: GO:0002062
label: chondrocyte differentiation
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: chondrocyte differentiation is consistent with RUNX3 developmental or
disease-associated transcriptional programs but is not the core molecular function.
action: KEEP_AS_NON_CORE
reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
RUNX3 transcription factor activity and should not be treated as the core function itself.
supported_by: *id001
- term:
id: GO:0003677
label: DNA binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Generic DNA binding is directionally correct but less precise than RUNX3
sequence-specific regulatory DNA binding.
action: MODIFY
reason: RUNX3 is not merely a generic DNA-binding protein; its supported molecular role is
sequence-specific Runt-domain binding at regulatory regions.
proposed_replacement_terms:
- id: GO:1990837
label: sequence-specific double-stranded DNA binding
- id: GO:0000978
label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
supported_by: *id003
- term:
id: GO:0003700
label: DNA-binding transcription factor activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Generic DNA-binding transcription factor activity is correct but less precise than the
RNA polymerase II-specific term already present.
action: MODIFY
reason: RUNX3 functions as a sequence-specific RNA polymerase II transcription factor, so the
more specific term is preferred.
proposed_replacement_terms: &id010
- id: GO:0000981
label: DNA-binding transcription factor activity, RNA polymerase II-specific
supported_by: *id002
- term:
id: GO:0005524
label: ATP binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: ATP binding is not supported as a RUNX3 molecular function.
action: REMOVE
reason: RUNX3 is a non-enzymatic DNA-binding transcription factor; ATP-dependent
chromatin-remodeling context should not be transferred to RUNX3 as ATP binding.
supported_by: &id011
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
primary function is as a **sequence-specific DNA-binding transcription factor** that
regulates gene expression programs by binding target regulatory elements via the **Runt
domain**, typically stabilized by heterodimerization with **CBFβ**.
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: &id005
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin
and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization**
can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides
a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export
machinery.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: Because RUNX3 is a transcription factor, **nuclear localization** is
essential for its canonical function. A recurring cancer mechanism is **functional
inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional
regulation).
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: cytoplasm localization is supported, but mainly as a mislocalization/export or
degradation context rather than the canonical site of RUNX3 function.
action: KEEP_AS_NON_CORE
reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
localization is best treated as a regulated non-core or inactivation-associated state.
supported_by: &id006
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin
and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization**
can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides
a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export
machinery.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: This provides a mechanistic explanation for the often-cited phenomenon of
RUNX3 cytoplasmic mislocalization as a route to functional loss.
- term:
id: GO:0006355
label: regulation of DNA-templated transcription
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Generic regulation of DNA-templated transcription is supported but should be captured
with the RNA polymerase II-specific process.
action: MODIFY
reason: RUNX3 target-gene regulation is best represented by regulation of transcription by RNA
polymerase II.
proposed_replacement_terms: &id012
- id: GO:0006357
label: regulation of transcription by RNA polymerase II
supported_by: *id002
- term:
id: GO:0045893
label: positive regulation of DNA-templated transcription
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Positive regulation of DNA-templated transcription is supported in context-specific
RUNX3 target-gene programs.
action: ACCEPT
reason: RUNX3 can activate transcriptional targets, although the direction of regulation is
context dependent.
supported_by: &id008
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
primary function is as a **sequence-specific DNA-binding transcription factor** that
regulates gene expression programs by binding target regulatory elements via the **Runt
domain**, typically stabilized by heterodimerization with **CBFβ**.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: A 2024 study (Cancer Research Communications) presented evidence that RUNX3
can be **pro-metastatic** in a gastric cancer model (HGC-27), where CRISPR KO reduced
migration/invasion/anchorage-independent growth and suppressed liver metastasis in vivo.
Multi-omic mapping (ChIP-seq, HiChIP) supported direct transcriptional control of
metastasis-associated targets including **WNT5A**, **CD44**, and **VIM**, with WNT5A
functioning as a major effector.
- term:
id: GO:1990837
label: sequence-specific double-stranded DNA binding
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: sequence-specific double-stranded DNA binding is supported by RUNX3 Runt-domain
sequence-specific DNA binding.
action: ACCEPT
reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor
function.
supported_by: *id003
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:18772112
review:
summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
main function.
action: MARK_AS_OVER_ANNOTATED
reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
chromatin factors, but the unqualified protein binding term is not informative for curation.
supported_by: &id004
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors
defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with
CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and
modulates transcriptional activity.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: 'A key 2023 advance demonstrated a **direct protein–protein mechanism** linking
RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s
transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation
of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation
of MYC.'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:24229708
review:
summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
main function.
action: MARK_AS_OVER_ANNOTATED
reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
chromatin factors, but the unqualified protein binding term is not informative for curation.
supported_by: *id004
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
review:
summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
main function.
action: MARK_AS_OVER_ANNOTATED
reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
chromatin factors, but the unqualified protein binding term is not informative for curation.
supported_by: *id004
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:38424632
review:
summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
main function.
action: MARK_AS_OVER_ANNOTATED
reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
chromatin factors, but the unqualified protein binding term is not informative for curation.
supported_by: *id004
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:9751710
review:
summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
main function.
action: MARK_AS_OVER_ANNOTATED
reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
chromatin factors, but the unqualified protein binding term is not informative for curation.
supported_by: *id004
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005829
label: cytosol
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: cytosol localization is supported, but mainly as a mislocalization/export or
degradation context rather than the canonical site of RUNX3 function.
action: KEEP_AS_NON_CORE
reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
localization is best treated as a regulated non-core or inactivation-associated state.
supported_by: *id006
- term:
id: GO:0006357
label: regulation of transcription by RNA polymerase II
evidence_type: IDA
original_reference_id: PMID:20591170
review:
summary: Regulation of transcription by RNA polymerase II is a core RUNX3 biological process.
action: ACCEPT
reason: RUNX3 regulates gene-expression programs as a nuclear sequence-specific transcription
factor.
supported_by: *id002
- term:
id: GO:0001222
label: transcription corepressor binding
evidence_type: IPI
original_reference_id: PMID:9751710
review:
summary: Transcription corepressor binding is supported by RUNX/Runt-domain recruitment of
TLE/Groucho corepressors.
action: ACCEPT
reason: This is a more informative binding annotation than generic protein binding for
RUNX3-associated transcriptional repression.
supported_by:
- reference_id: PMID:9751710
supporting_text: The mammalian AML/CBFalpha runt domain (RD) transcription factors regulate
hematopoiesis and osteoblast differentiation. Like their Drosophila counterparts, most
mammalian RD proteins terminate in a common pentapeptide, VWRPY, which serves to recruit the
corepressor Groucho (Gro).
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
primary function is as a **sequence-specific DNA-binding transcription factor** that
regulates gene expression programs by binding target regulatory elements via the **Runt
domain**, typically stabilized by heterodimerization with **CBFβ**.
- term:
id: GO:1990837
label: sequence-specific double-stranded DNA binding
evidence_type: IDA
original_reference_id: PMID:28473536
review:
summary: sequence-specific double-stranded DNA binding is supported by RUNX3 Runt-domain
sequence-specific DNA binding.
action: ACCEPT
reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor
function.
supported_by: *id003
- term:
id: GO:0000785
label: chromatin
evidence_type: ISA
original_reference_id: GO_REF:0000113
review:
summary: Chromatin localization is supported by RUNX3 DNA, mononucleosome, and
chromatin-remodeler-associated activity.
action: ACCEPT
reason: RUNX3 binds chromatin-associated regulatory DNA as part of its transcription factor
function.
supported_by: &id009
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin
accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 associates with **CBFβ** and chromatin remodeler machinery including
SWI/SNF components; the **Runt domain** is implicated as critical for interactions with
chromatin factors in this metastatic gastric cancer model.
- term:
id: GO:0000981
label: DNA-binding transcription factor activity, RNA polymerase II-specific
evidence_type: ISA
original_reference_id: GO_REF:0000113
review:
summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the
best-supported core molecular function of RUNX3.
action: ACCEPT
reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA
polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
supported_by: *id002
- term:
id: GO:0016513
label: core-binding factor complex
evidence_type: TAS
original_reference_id: PMID:18258917
review:
summary: Core-binding factor complex is the canonical RUNX3 transcription factor complex
context.
action: ACCEPT
reason: RUNX3 heterodimerizes with CBFβ, placing it in the core-binding factor complex for
DNA-binding transcriptional regulation.
supported_by:
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors
defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with
CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and
modulates transcriptional activity.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 associates with **CBFβ** and chromatin remodeler machinery including
SWI/SNF components; the **Runt domain** is implicated as critical for interactions with
chromatin factors in this metastatic gastric cancer model.
- term:
id: GO:0043371
label: negative regulation of CD4-positive, alpha-beta T cell differentiation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: negative regulation of CD4-positive, alpha-beta T cell differentiation is a supported
RUNX3 biological role, especially in immune differentiation, but it is downstream of the
transcription factor core function.
action: KEEP_AS_NON_CORE
reason: T-cell differentiation phenotypes reflect RUNX3-regulated transcriptional programs
rather than a separate core molecular activity.
supported_by: &id007
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 is a key regulator of **CD8+ T-cell differentiation, infiltration,
effector/memory fate, and residency**.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: '**RUNX3 is a master developmental transcription factor** whose dysregulation can
impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).'
- term:
id: GO:0043378
label: positive regulation of CD8-positive, alpha-beta T cell differentiation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: positive regulation of CD8-positive, alpha-beta T cell differentiation is a supported
RUNX3 biological role, especially in immune differentiation, but it is downstream of the
transcription factor core function.
action: KEEP_AS_NON_CORE
reason: T-cell differentiation phenotypes reflect RUNX3-regulated transcriptional programs
rather than a separate core molecular activity.
supported_by: *id007
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952419
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952399
review:
summary: cytosol localization is supported, but mainly as a mislocalization/export or
degradation context rather than the canonical site of RUNX3 function.
action: KEEP_AS_NON_CORE
reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
localization is best treated as a regulated non-core or inactivation-associated state.
supported_by: *id006
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952408
review:
summary: cytosol localization is supported, but mainly as a mislocalization/export or
degradation context rather than the canonical site of RUNX3 function.
action: KEEP_AS_NON_CORE
reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
localization is best treated as a regulated non-core or inactivation-associated state.
supported_by: *id006
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952382
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952399
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8951966
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8951977
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952058
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952062
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952069
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8937792
review:
summary: cytosol localization is supported, but mainly as a mislocalization/export or
degradation context rather than the canonical site of RUNX3 function.
action: KEEP_AS_NON_CORE
reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
localization is best treated as a regulated non-core or inactivation-associated state.
supported_by: *id006
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8937807
review:
summary: cytosol localization is supported, but mainly as a mislocalization/export or
degradation context rather than the canonical site of RUNX3 function.
action: KEEP_AS_NON_CORE
reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
localization is best treated as a regulated non-core or inactivation-associated state.
supported_by: *id006
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8937814
review:
summary: cytosol localization is supported, but mainly as a mislocalization/export or
degradation context rather than the canonical site of RUNX3 function.
action: KEEP_AS_NON_CORE
reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
localization is best treated as a regulated non-core or inactivation-associated state.
supported_by: *id006
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8865454
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8878117
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8878143
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8878178
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8878193
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8878220
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8878237
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8937814
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8949335
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8951428
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8951676
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8951910
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8951951
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952128
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952226
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8952371
review:
summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20599712
review:
summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
main function.
action: MARK_AS_OVER_ANNOTATED
reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
chromatin factors, but the unqualified protein binding term is not informative for curation.
supported_by: *id004
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:20599712
review:
summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:20599712
review:
summary: cytoplasm localization is supported, but mainly as a mislocalization/export or
degradation context rather than the canonical site of RUNX3 function.
action: KEEP_AS_NON_CORE
reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
localization is best treated as a regulated non-core or inactivation-associated state.
supported_by: *id006
- term:
id: GO:0045893
label: positive regulation of DNA-templated transcription
evidence_type: IDA
original_reference_id: PMID:20599712
review:
summary: Positive regulation of DNA-templated transcription is supported in context-specific
RUNX3 target-gene programs.
action: ACCEPT
reason: RUNX3 can activate transcriptional targets, although the direction of regulation is
context dependent.
supported_by: *id008
- term:
id: GO:0071559
label: response to transforming growth factor beta
evidence_type: IDA
original_reference_id: PMID:20599712
review:
summary: Response to transforming growth factor beta is supported as a pathway context for RUNX3
transcriptional regulation.
action: KEEP_AS_NON_CORE
reason: TGF-beta/SMAD effects are important context-specific biology, but the core function
remains nuclear sequence-specific transcriptional regulation.
supported_by:
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator
embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and
**Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter
hypermethylation, histone modifications, and mislocalization**.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: '**RUNX3 is a master developmental transcription factor** whose dysregulation can
impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17377532
review:
summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
main function.
action: MARK_AS_OVER_ANNOTATED
reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
chromatin factors, but the unqualified protein binding term is not informative for curation.
supported_by: *id004
- term:
id: GO:0000785
label: chromatin
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Chromatin localization is supported by RUNX3 DNA, mononucleosome, and
chromatin-remodeler-associated activity.
action: ACCEPT
reason: RUNX3 binds chromatin-associated regulatory DNA as part of its transcription factor
function.
supported_by: *id009
- term:
id: GO:0000977
label: RNA polymerase II transcription regulatory region sequence-specific DNA binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: RNA polymerase II transcription regulatory region sequence-specific DNA binding is
supported by RUNX3 Runt-domain sequence-specific DNA binding.
action: ACCEPT
reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor
function.
supported_by: *id003
- term:
id: GO:0000122
label: negative regulation of transcription by RNA polymerase II
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Negative regulation of transcription by RNA polymerase II is supported for RUNX3 in
repressive target-gene and Wnt/TCF contexts.
action: ACCEPT
reason: RUNX3 can repress transcriptional outputs through protein complexes and target-gene
regulation.
supported_by:
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
primary function is as a **sequence-specific DNA-binding transcription factor** that
regulates gene expression programs by binding target regulatory elements via the **Runt
domain**, typically stabilized by heterodimerization with **CBFβ**.
- reference_id: PMID:18772112
supporting_text: Here we found that RUNX3, a gastric tumor suppressor, forms a ternary complex
with beta-catenin/TCF4 and attenuates Wnt signaling activity.
- term:
id: GO:0000981
label: DNA-binding transcription factor activity, RNA polymerase II-specific
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the
best-supported core molecular function of RUNX3.
action: ACCEPT
reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA
polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
supported_by: *id002
- term:
id: GO:0048935
label: peripheral nervous system neuron development
evidence_type: TAS
original_reference_id: PMID:20096094
review:
summary: peripheral nervous system neuron development is consistent with RUNX3 developmental or
disease-associated transcriptional programs but is not the core molecular function.
action: KEEP_AS_NON_CORE
reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
RUNX3 transcription factor activity and should not be treated as the core function itself.
supported_by: *id001
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:20100835
review:
summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
action: ACCEPT
reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
supported_by: *id005
- term:
id: GO:0006468
label: protein phosphorylation
evidence_type: IDA
original_reference_id: PMID:20100835
review:
summary: Protein phosphorylation is not supported as a process carried out by RUNX3.
action: REMOVE
reason: The cited biology describes Src-mediated phosphorylation of RUNX3, making RUNX3 the
substrate rather than the kinase or causal gene product for protein phosphorylation.
supported_by:
- reference_id: PMID:20100835
supporting_text: In this study, we found that the overexpression of Src results in the
tyrosine phosphorylation and cytoplasmic localization of RUNX3.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin
and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization**
can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides
a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export
machinery.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20100835
review:
summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
main function.
action: MARK_AS_OVER_ANNOTATED
reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
chromatin factors, but the unqualified protein binding term is not informative for curation.
supported_by: *id004
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:20100835
review:
summary: cytoplasm localization is supported, but mainly as a mislocalization/export or
degradation context rather than the canonical site of RUNX3 function.
action: KEEP_AS_NON_CORE
reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
localization is best treated as a regulated non-core or inactivation-associated state.
supported_by: *id006
- term:
id: GO:0045786
label: negative regulation of cell cycle
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: negative regulation of cell cycle is consistent with RUNX3 developmental or
disease-associated transcriptional programs but is not the core molecular function.
action: KEEP_AS_NON_CORE
reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
RUNX3 transcription factor activity and should not be treated as the core function itself.
supported_by: *id001
- term:
id: GO:0050680
label: negative regulation of epithelial cell proliferation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: negative regulation of epithelial cell proliferation is consistent with RUNX3
developmental or disease-associated transcriptional programs but is not the core molecular
function.
action: KEEP_AS_NON_CORE
reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
RUNX3 transcription factor activity and should not be treated as the core function itself.
supported_by: *id001
- term:
id: GO:0003700
label: DNA-binding transcription factor activity
evidence_type: TAS
original_reference_id: PMID:7607690
review:
summary: Generic DNA-binding transcription factor activity is correct but less precise than the
RNA polymerase II-specific term already present.
action: MODIFY
reason: RUNX3 functions as a sequence-specific RNA polymerase II transcription factor, so the
more specific term is preferred.
proposed_replacement_terms: *id010
supported_by: *id002
- term:
id: GO:0005524
label: ATP binding
evidence_type: NAS
original_reference_id: PMID:7835892
review:
summary: ATP binding is not supported as a RUNX3 molecular function.
action: REMOVE
reason: RUNX3 is a non-enzymatic DNA-binding transcription factor; ATP-dependent
chromatin-remodeling context should not be transferred to RUNX3 as ATP binding.
supported_by: *id011
- term:
id: GO:0006355
label: regulation of DNA-templated transcription
evidence_type: NAS
original_reference_id: PMID:7622058
review:
summary: Generic regulation of DNA-templated transcription is supported but should be captured
with the RNA polymerase II-specific process.
action: MODIFY
reason: RUNX3 target-gene regulation is best represented by regulation of transcription by RNA
polymerase II.
proposed_replacement_terms: *id012
supported_by: *id002
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by
curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary
mapping, accompanied by conservative changes to GO terms applied by UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000113
title: Gene Ontology annotation of human sequence-specific DNA binding transcription factors
(DbTFs) based on the TFClass database
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:17377532
title: Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
findings: []
- id: PMID:18258917
title: Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell
development.
findings: []
- id: PMID:18772112
title: RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
findings: []
- id: PMID:20096094
title: Brn3a regulates neuronal subtype specification in the trigeminal ganglion by promoting Runx
expression during sensory differentiation.
findings: []
- id: PMID:20100835
title: Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the
cytoplasm.
findings: []
- id: PMID:20591170
title: The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer
cells.
findings: []
- id: PMID:20599712
title: Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt
domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
findings: []
- id: PMID:24229708
title: Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.
findings: []
- id: PMID:28473536
title: Impact of cytosine methylation on DNA binding specificities of human transcription factors.
findings: []
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
findings: []
- id: PMID:38424632
title: Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in
lung adenocarcinoma.
findings: []
- id: PMID:7607690
title: Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the
human homolog, CBFA3, to chromosome 1p35-pter.
findings: []
- id: PMID:7622058
title: Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt
domain.
findings: []
- id: PMID:7835892
title: 'AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression,
and chromosomal localization.'
findings: []
- id: PMID:9751710
title: Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors.
findings: []
- id: Reactome:R-HSA-8865454
title: CBFB binds RUNX3
findings: []
- id: Reactome:R-HSA-8878117
title: RUNX3 binds ZFHX3
findings: []
- id: Reactome:R-HSA-8878143
title: RUNX3 binds SMAD3 and SMAD4
findings: []
- id: Reactome:R-HSA-8878178
title: The complex of RUNX3, SMAD3 and SMAD4 binds the CDKN1A gene promoter
findings: []
- id: Reactome:R-HSA-8878193
title: RUNX3 binds the JAG1 gene promoter
findings: []
- id: Reactome:R-HSA-8878220
title: RUNX3 binds the NOTCH1 coactivator complex
findings: []
- id: Reactome:R-HSA-8878237
title: RUNX3:NOTCH1 coactivator complex binds the HES1 gene promoter
findings: []
- id: Reactome:R-HSA-8937792
title: RUNX3 binds SRC
findings: []
- id: Reactome:R-HSA-8937807
title: SRC phosphorylates RUNX3
findings: []
- id: Reactome:R-HSA-8937814
title: RUNX3 translocates to the nucleus
findings: []
- id: Reactome:R-HSA-8949335
title: RUNX3:CBFB binds the ITGAL gene,(ITGA4 gene) promoter
findings: []
- id: Reactome:R-HSA-8951428
title: RUNX3 binds CTNNB1:TCF7L2,(LEF1,TCF7L1,TCF7)
findings: []
- id: Reactome:R-HSA-8951676
title: RUNX3 binds TEADs and YAP1
findings: []
- id: Reactome:R-HSA-8951910
title: RUNX3 binds the RUNX1 promoter
findings: []
- id: Reactome:R-HSA-8951951
title: RUNX3 binds EP300
findings: []
- id: Reactome:R-HSA-8951966
title: EP300 acetylates RUNX3
findings: []
- id: Reactome:R-HSA-8951977
title: Acetylated RUNX3 binds to BRD2
findings: []
- id: Reactome:R-HSA-8952058
title: CCND1 binds RUNX3 and displaces EP300
findings: []
- id: Reactome:R-HSA-8952062
title: CCND1 recruits HDAC4 to RUNX3
findings: []
- id: Reactome:R-HSA-8952069
title: HDAC4 deacetylates RUNX3
findings: []
- id: Reactome:R-HSA-8952128
title: RUNX3 binds TP53
findings: []
- id: Reactome:R-HSA-8952226
title: RUNX3 binds the BCL2L11 (BIM) gene
findings: []
- id: Reactome:R-HSA-8952371
title: MDM2 binds RUNX3
findings: []
- id: Reactome:R-HSA-8952382
title: MDM2 polyubiquitinates RUNX3
findings: []
- id: Reactome:R-HSA-8952399
title: Polyubiquitinated RUNX3 translocates to the cytosol
findings: []
- id: Reactome:R-HSA-8952408
title: Polyubiquitinated RUNX3 is degraded by the proteasome
findings: []
- id: Reactome:R-HSA-8952419
title: SMURFs ubiquitinate RUNX3
findings: []
- id: file:human/RUNX3/RUNX3-deep-research-falcon.md
title: Falcon deep research synthesis for RUNX3
findings: []
core_functions:
- description: Nuclear Runt-domain sequence-specific transcription factor activity in
CBFβ/core-binding factor complexes, regulating RNA polymerase II target-gene programs through
chromatin and regulatory-region DNA binding.
molecular_function:
id: GO:0000981
label: DNA-binding transcription factor activity, RNA polymerase II-specific
directly_involved_in:
- id: GO:0006357
label: regulation of transcription by RNA polymerase II
- id: GO:0045893
label: positive regulation of DNA-templated transcription
- id: GO:0000122
label: negative regulation of transcription by RNA polymerase II
locations:
- id: GO:0005634
label: nucleus
- id: GO:0005654
label: nucleoplasm
- id: GO:0000785
label: chromatin
in_complex:
id: GO:0016513
label: core-binding factor complex
supported_by:
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
primary function is as a **sequence-specific DNA-binding transcription factor** that regulates
gene expression programs by binding target regulatory elements via the **Runt domain**,
typically stabilized by heterodimerization with **CBFβ**.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors
defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with
CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and
modulates transcriptional activity.
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin
accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
- reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
supporting_text: RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin
and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization**
can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a
mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
proposed_new_terms: []
suggested_questions: []
suggested_experiments: []